secwatch.observer — SEC 8-K summary
======================================

Issuer:     Grace Therapeutics, Inc. (GRCE)
CIK:        0001444192
Form:       8-K
Filed at:   2026-06-18T12:15:34+00:00
Accession:  0001140361-26-025669
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Grace Therapeutics updates corporate presentation; no specific details available in filing
--------------------------------------------------------------------------------

- Filed updated corporate presentation as Exhibit 99.1 dated June 17, 2026.
- Presentation content not fully included in the filing; unable to assess material changes.
- No financial or operational metrics disclosed in the 8-K body.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1444192/000114036126025669/0001140361-26-025669-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1444192/000114036126025669/ef20076431_form8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-025669

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer